Announcement on the Implementation of Annual Equity Distribution of Zhejiang Ausun Pharmaceutical in 2023.
Announcement of Resolutions of Aoxiang Pharmaceutical's 2023 Annual General Meeting of Shareholders
Legal Opinion of Aoxiang Pharmaceutical's 2023 Annual General Meeting of Shareholders
Aoxiang Pharmaceutical 2023 Annual Shareholders' Meeting Meeting Materials
Aoxiang Pharmaceutical's announcement on applying for comprehensive credit lines from financial institutions in 2024
Aoxiang Pharmaceutical's announcement on the company's 2024 external guarantee amount forecast
Aoxiang Pharmaceutical's announcement on the use of some idle funds raised to temporarily supplement working capital
Aoxiang Pharmaceutical 2023 Annual Report
Aoxiang Pharmaceutical 2023 Audit Report
Inspection opinions of Guojin Securities Co., Ltd. on Zhejiang Aoxiang Pharmaceutical Co., Ltd.'s use of some idle funds raised to temporarily supplement working capital
Notice of Aoxiang Pharmaceutical on amending the “Articles of Association”
Aoxiang Pharmaceutical's announcement on the use of idle own funds for cash management
Aoxiang Pharmaceutical Company Constitution
Aoxiang Pharmaceutical's Notice on Convening the 2023 Annual General Meeting of Shareholders
Aoxiang Pharmaceutical's announcement on holding a performance briefing for the first quarter of 2023 and 2024
Announcement of Resolutions of the 2nd Meeting of the 4th Supervisory Committee of Aoxiang Pharmaceutical
Aoxiang Pharmaceutical's 2024 First Quarter Report
Aoxiang Pharmaceutical's announcement on renewing the 2024 Audit Institution
Aoxiang Pharmaceutical's Feasibility Analysis Report on Launching Foreign Exchange Derivatives Trading in 2024
Aoxiang Pharmaceutical's announcement on the launch of foreign exchange derivatives trading in 2024
No Data